Sio Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.07M Buy
3,634,137
+1,000,000
+38% +$1.3M 1.15% 30
2026
Q2
$3.53M Sell
2,634,137
-442,443
-14% -$568K 0.58% 40
2026
Q1
$3.81M Buy
3,076,580
+440,032
+17% +$560K 0.55% 44
2025
Q4
$3.3M Hold
2,636,548
– – 0.52% 40
2025
Q3
$3.69M Sell
2,636,548
-1,098,848
-29% -$1.52M 0.93% 28
2025
Q2
$3.96M Hold
3,735,396
– – 1.51% 20
2025
Q1
$4.07M Buy
3,735,396
+163,229
+5% +$222K 1.21% 21
2024
Q4
$5.39M Buy
3,572,167
+357,928
+11% +$567K 1.52% 23
2024
Q3
$4.79M Buy
3,214,239
+505,831
+19% +$782K 1.9% 18
2024
Q2
$4.39M Buy
+2,708,408
New +$4.88M 1.19% 21
2020
Q4
– Sell
-1,000
Closed -$36K – 105
2020
Q3
$36K Buy
+1,000
New +$36.8K 0.01% 89

Other funds holding PMVP

Sio Capital Management's PMVP Position: Q3 2026 in Review

Sio Capital Management increased its PMV Pharmaceuticals (PMVP) stake by 38% in Q3 2026, buying an estimated $1.3M and bringing the position to 3,634,137 shares worth $6.07M. The position accounts for 1.15% of the portfolio, ranked #30.

Sio Capital Management first reported a position in PMVP in Q3 2020 and has held it in 11 quarters since. 65 funds tracked by Wall St. Rank hold PMVP as of Q3 2026.

  • Sio Capital Management held 3,634,137 shares of PMV Pharmaceuticals worth $6.07M as of Q3 2026.
  • Sio Capital Management bought 1,000,000 PMV Pharmaceuticals shares in Q3 2026, an estimated $1.3M.
  • PMV Pharmaceuticals made up 1.15% of Sio Capital Management's portfolio in Q3 2026, its #30 holding.
  • Sio Capital Management first reported a position in PMV Pharmaceuticals in Q3 2020 and has held it in 11 quarters since.
  • 65 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2026.

Based on Sio Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.